Massimo Andreoni

April 29, 2022
Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection
Summary At a time when hepatitis C virus clearance can be obtained by DAAs in almost all infected patients, global infection burden control is an objective within reach, even if achieving the WHO HCV elimination targets by 2030 may not be attainable. The lowest cost intervention is an awareness campaign to bring in those who […]

Read More
June 19, 2014
Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
Summary Background At present, there are no specific nationwide epidemiological studies representing the whole Italian population. This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. This […]

Read More

English